The BASIL trial led to a number of recommendations, many of which have been actively embraced by NICE as part of their Peripheral Arterial Disease (PAD) Clinical Guidelines.
The impact of these findings and their clinical uptake is not limited to the UK. Following publication of the trial outcomes Professor Bradbury has been invited to present the BASIL data in Europe, the Middle and Far East, North and South America and Australia. The novel insights and recommendations emanating from BASIL were consequently adopted into and highlighted in a number of key international guidelines which are now guiding clinical practice in this area.
As a result of this work, the World Federation of Vascular Societies, (WFVS) Society for Vascular Surgery (SVS) and European Society for Vascular Surgery (ESVS) have agreed on the need for clear standards for peripheral arterial care, and are working together to develop standard guidelines.
These societies represent almost all vascular surgical societies in the countries in the world, and Professor Bradbury will now lead the discussions and collaborations across not only Europe but also Asia, Australasia and Southern Africa that take this important area of patient care forward.